Presence of androgen receptor splice variants in circulating tumor cells and response to cabazitaxel in castration-resistant prostate cancer

被引：0

作者：

Onstenk, W. ^{[1
]}

Sieuwerts, A. ^{[1
]}

Kraan, J. ^{[1
]}

Van, M. ^{[1
]}

Nieuweboer, A. ^{[1
]}

Mathijssen, R. ^{[1
]}

Hamberg, P. ^{[2
]}

Meulenbeld, H. ^{[3
]}

DeLaere, B. ^{[4
,5
]}

Dirix, L. ^{[4
,5
]}

Van Soest, R. ^{[6
]}

Lolkema, M. ^{[1
]}

Martens, J. ^{[1
]}

Van Weerden, W. ^{[6
]}

Jenster, G. ^{[6
]}

Foekens, J. ^{[1
]}

De Wit, R. ^{[1
]}

Sleijfer, S. ^{[1
]}

机构：

[1] Erasmus MC Canc Inst, Med Oncol, Rotterdam, Netherlands

[2] St Franciscus Gasthuis, Internal Med, Rottedam, Netherlands

[3] Gelre Ziekenhuizen, Internal Med, Zutphen, Netherlands

[4] Univ Antwerp, GZA Hosp Sint Augustinus, Antwerp, Belgium

[5] Oncol Res Ctr, Antwerp, Belgium

[6] Erasmus MC, Urol, Rotterdam, Netherlands

来源：

EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷

关键词：

D O I：

10.1016/S0959-8049(16)31394-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2575

引用

页码：S503 / S503

页数：1

共 50 条

[41] Nuclear Circulating Tumor Cell Androgen Receptor Variant 7 in Castration-Resistant Prostate Cancer The Devil Is in the Detail
Plymate, Stephen R.
Sharp, Adam
de Bono, Johann S.
JAMA ONCOLOGY, 2018, 4 (09) : 1187 - 1188
[42] Circulating Tumor Cells and Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer
Pleskow, H.
Otani, K.
Kusaka, E.
Ukleja, J.
Balza, R.
Fisher, R.
Broderick, K.
Maheswaran, S.
Haber, D.
Saylor, P. J.
Miyamoto, D. T.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E534 - E535
[43] Circulating tumor cells (CTC) gene expression and plasma androgen receptor (AR) copy number (CN) in cabazitaxel-treated metastatic castration-resistant prostate cancer (mCRPC)
Gurioli, G.
Conteduca, V.
Brighi, N.
Scarpi, E.
Basso, U.
Fornarini, G.
Mosca, A.
Nicodemo, M.
Banna, G. L.
Lolli, C.
Schepisi, G.
Ravaglia, G.
Ulivi, P.
De Giorgi, U.
ANNALS OF ONCOLOGY, 2021, 32 : S654 - S655
[44] Prevalence and heterogeneity of androgen receptor splice variants and intra-AR structural variation in patient with castration-resistant prostate cancer
Dirix, Luc Yves
De Laere, Bram
van Dam, Pieter-Jan
Whitington, Tom
Mayrhofer, Markus
Diaz, Emanuele Henao
Van den Eynden, Gert
Vandebroek, Jean
Del-Favero, Jurgen
Van Laere, Steven J.
Gronberg, Henrik
Lindberg, Johan
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[45] Dynamic variations in gene expressions of circulating tumor cells in metastatic castration-resistant prostate cancer patients in response to androgen receptor signaling inhibitors.
Jan, Yu Jen
You, Sungyong
Yoon, Junhee
Chen, Jie-Fu
Yao, Nu
Cheng, Shirley
Freeman, Michael
Tseng, Hsian-Rong
Posadas, Edwin M.
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[46] Blocking GRP/GRP-R signaling decreases expression of androgen receptor splice variants and inhibits tumor growth in castration-resistant prostate cancer
Case, Thomas C.
Merkel, Alyssa
Ramirez-Solano, Marisol
Liu, Qi
Sterling, Julie A.
Jin, Renjie
TRANSLATIONAL ONCOLOGY, 2021, 14 (11):
[47] Targeting the androgen receptor in metastatic castration-resistant prostate cancer
Aragon-Ching, Jeanny B.
FUTURE ONCOLOGY, 2014, 10 (03) : 329 - 332
[48] Circulating tumor cells as liquid biopsy for castration resistant prostate cancer patients treated with cabazitaxel
Salvi, S.
Conteduca, V.
Casadio, V.
Fici, P.
Gurioli, G.
Martignano, F.
Basso, U.
Fornarini, G.
Lolli, C.
Schepisi, G.
Testoni, S.
Calistri, D.
De Giorgi, U.
ANNALS OF ONCOLOGY, 2017, 28
[49] Androgen receptor (AR) aberrations in castration-resistant prostate cancer
Waltering, Kati K.
Urbanucci, Alfonso
Visakorpi, Tapio
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2012, 360 (1-2) : 38 - 43
[50] Androgen Receptor Signaling in the Development of Castration-Resistant Prostate Cancer
Feng, Qin
He, Bin
FRONTIERS IN ONCOLOGY, 2019, 9

← 1 2 3 4 5 →